Inhibition of Focal Adhesion Kinase in Combination With Bevacizumab Reduces the Rate of Tumor Revascularization and Increases Survival in a Pre-clinical Model of Basal Breast Cancer
- Author(s)
- Street, I; Holmes, I; Devlin, M; Bergman, Y; Doherty, J; Natoli, A; Falk, H; Nikac, M; Choi, N; Walker, S;
- Journal Title
- EUROPEAN JOURNAL OF CANCER
- Publication Type
- Meeting Abstract
- Publisher
- ELSEVIER SCI LTD
- Research Division(s)
- Chemical Biology
- Terms of Use/Rights Notice
- Copyright © 2012 Elsevier Inc. All rights reserved.
Creation Date: 2012-01-01 12:00:00